|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/12 | (2006.01) |
| A61K 39/12 | (2013.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61K2039/55505 | (2013.01) | ||
| C12N2770/24134 | (2013.01) | ||
| A61K 47/02 | (2013.01) | ||
| A61K2039/5252 | (2013.01) | ||
| A61K 39/104 | (2013.01) | ||
| A61K 39/39 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3785730 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20184308.3 |
| Date of filing the European patent application | 2012-12-06 | |
| (97) | Date of publication of the European application | 2021-03-03 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 11192230 | 2011-12-06 | EP | |
| PCT/EP2012/054387 | 2012-03-13 | WO |
| (72) |
Möhlen, Michael , AT
Weber, Michael , AT
Wruss, Jürgen , AT
Schlegl, Robert , AT
|
| (73) |
Valneva Austria GmbH ,
Campus Vienna Biocenter 3, 1030 Vienna,
AT
|
| (54) | ALUMINIUM COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES |
| ALUMINIUM COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES |